scienceMar 10, 202423:05pending

Ep. 87: Biomarker-based diagnosis of Alzheimer

About this episode

Moderator: Youssuf Saleh (Oxford, United Kingdom) Guest: Sebastiaan Engelborghs (Brussel, Belgium) Youssuf Saleh interviews Prof. Sebastiaan Engelborghs on Alzheimer's biomarkers, focusing on amyloid and tau. They discuss diagnostic challenges, the need for prognostic markers, and potential serum markers like neurofilament light. Engelborghs highlights Alzheimer's complexity and the role of omics studies in patient subpopulations. The interview concludes with optimism for blood-based biomarkers revolutionizing diagnosis in the next five years, contingent on clinical validation and evolving therapies.

Get every episode summarized

Each time eanCast: Weekly Neurology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

eean.orgHost

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

More episodes

Ep. 87: Biomarker-based diagnosis of Alzheimer

About this episode

Get every episode summarized

Hosts & guests

More from eanCast: Weekly Neurology

Ep. 193: Understanding GBS and other inflammatory neuropathies across ages

Ep. 192: Movement disorders in children and adults: different or the same?

Ep. 191: FND in children and adults: different or the same?

Ep. 190: Parkinson’s disease – more than a movement disorder